21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer

BACKGROUND/PURPOSE: The 21-gene recurrence score (RS) assay evaluates the likelihood of distant recurrence and benefit of chemotherapy in lymph node-negative, estrogen receptor (ER)-positive, HER2-negative breast cancer patients. The RS categories are associated with the risk of locoregional recurre...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Breast Cancer Res Treat
Asıl Yazarlar: Turashvili, Gulisa, Chou, Joanne F., Brogi, Edi, Morrow, Monica, Dickler, Maura, Norton, Larry, Hudis, Clifford, Wen, Hannah Y
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5647226/
https://ncbi.nlm.nih.gov/pubmed/28702894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4381-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller